Sam Sharifi

Sam Sharifi, PhD, is a prominent figure in the biotechnology sector, currently serving as Chief Scientific Officer and Co-founder at Matter Bio, Mutagentech, and Loki Therapeutics. With a strong focus on longevity and genome integrity, Sam's work spans various roles, including a former position as a Scientific Project Manager at Vincere Biosciences and a Scientific Researcher at the Fritz Lipmann Institute on Aging. Educationally, Sam holds a PhD from Friedrich Schiller University Jena, where research centered on rRNA synthesis and aging. Additional academic credentials include a Bachelor's degree from the University of Amsterdam and a Master's degree in Biomolecular Sciences from VU Amsterdam, complemented by training in biomedical innovation and entrepreneurship from SPARK Europe.